The proposed bill would significantly update current statutes regarding stem cell and regenerative therapies by introducing the "Arizona Stem Cell and Regenerative Therapy Act." It defines stem cell or regenerative therapy and establishes guidelines for providers to perform therapies that are not FDA-approved, contingent upon meeting specific criteria such as obtaining informed consent and ensuring compliance with sourcing requirements. The bill removes provisions prohibiting the use of cells or tissues derived from an aborted fetus or embryo and eliminates related felony penalties, thereby broadening the scope of practice to include any licensed health professional rather than limiting it to specific fields like orthopedics or pain management. Additionally, the bill mandates that facilities providing stem cells or regenerative medicines must be certified or accredited, and it requires detailed documentation and reporting of treatment outcomes and adverse events. It introduces new requirements for training, sourcing, and informed consent for providers, while also replacing the term physician with provider and birth tissue therapy with regenerative therapy. The legislation aims to enhance safety and accountability in the administration of these therapies, allowing for civil action against non-compliant providers while protecting those who act in good faith.

Statutes affected:
Introduced Version: